Opus Genetics IRD Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opus Genetics's net change in cash?
- Opus Genetics (IRD) reported net change in cash of $14.87M in Q1 2026.
- How has Opus Genetics's net change in cash changed year-over-year?
- Opus Genetics's net change in cash increased by 29.6% year-over-year, from $11.47M to $14.87M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.